Filing Details
- Accession Number:
- 0001645627-18-000054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-06 13:32:47
- Reporting Period:
- 2018-08-30
- Accepted Time:
- 2018-09-06 13:32:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 27,500 shares | Avg. Price: $0.05 | Total Value: $1,351.25 |
| Number of Shares After Transactions: | 25,855,198 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-30 | 2,000 | $0.04 | 25,829,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-30 | 1,000 | $0.04 | 25,830,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-30 | 2,000 | $0.04 | 25,832,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-30 | 1,000 | $0.04 | 25,833,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-30 | 1,000 | $0.04 | 25,834,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-31 | 2,000 | $0.05 | 25,836,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-31 | 2,000 | $0.05 | 25,838,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-31 | 1,000 | $0.05 | 25,839,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-31 | 1,000 | $0.05 | 25,840,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-31 | 2,000 | $0.05 | 25,842,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-31 | 1,000 | $0.05 | 25,843,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-31 | 1,000 | $0.05 | 25,844,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-31 | 500 | $0.05 | 25,845,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-04 | 1,000 | $0.05 | 25,846,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-04 | 1,000 | $0.05 | 25,847,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-04 | 1,000 | $0.05 | 25,848,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-04 | 1,000 | $0.05 | 25,849,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-04 | 2,000 | $0.05 | 25,851,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-04 | 2,000 | $0.05 | 25,853,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-04 | 2,000 | $0.05 | 25,855,198 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
